1 to 10 of 138 trials

• Fenofibrate and Pharmacogenetic Impact in Dyslipidemia

  conditions:	Dyslipidemia
  interventions:	fenofibrate ; fenofibrate
  last updated:	2009 Jun 12
  status:	recruiting
  sponsor:	University of Minnesota

   

• Fenofibrate Bioequivalence Study

  conditions:	Dyslipidemia
  interventions:	fenofibrate (US formulation) ; fenofibrate (UK formulation)
  last updated:	2009 Jun 25
  status:	completed
  sponsor:	Merck

   

• Effects of Fenofibrate on Adipocytokine Levels In Hypertriglyceridemic Patients

  conditions:	Hypertriglyceridemia
  interventions:	fenofibrate
  last updated:	2008 Sep 2
  status:	completed
  sponsor:	Gachon University Gil Medical Center

   

• Substrate Cycling in Energy Metabolism

  conditions:	Burns ; Insulin Resistance
  interventions:	fenofibrate
  last updated:	2007 Aug 22
  status:	completed
  sponsor:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

   

• LXRA Gene Polymorphisms and Response to Fenofibrate

  conditions:	Healthy
  interventions:	Fenofibrate ; Placebo
  last updated:	2008 Mar 25
  status:	recruiting
  sponsor:	University of Florida

   

• Effect of Fenofibrate on Sleep Apnea Syndrome

  conditions:	Dyslipidemia ; Sleep Apnea Syndrome ; Overweight ; Obesity
  interventions:	Placebo ; Fenofibrate
  last updated:	2009 Jul 17
  status:	terminated
  sponsor:	Solvay Pharmaceuticals

   

• Effect of TAK-475 Combined With Fenofibrate on Blood Cholesterol Levels

  conditions:	Hyperlipidemias
  interventions:	TAK-475 and fenofibrate ; Fenofibrate
  last updated:	2008 Dec 19
  status:	completed
  sponsor:	Takeda Global Research & Development Center, Inc.

   

• Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033

  conditions:	Obesity
  interventions:	CP-742,033 ; Fenofibrate
  last updated:	2006 Dec 11
  status:	withdrawn
  sponsor:	Pfizer

   

• Use of Fenofibrate for Primary Biliary Cirrhosis

  conditions:	Primary Biliary Cirrhosis
  interventions:	Fenofibrate (Insoluble Drug Delivery-Micro Particle Fenofibrate (IDD-P)
  last updated:	2007 Dec 13
  status:	recruiting
  sponsor:	University of Florida

   

• Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed Conditions

  conditions:	Healthy
  interventions:	Fenofibrate 160 mg tablets
  last updated:	2008 Oct 17
  status:	completed
  sponsor:	Ranbaxy Laboratories Limited